No Data
No Data
JonesTrading Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $105
Buy Rating for Janux Therapeutics Amidst Competitive Landscape and Advancements in Masked T-cell Engagers
Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer -- Barrons.com
Viking Therapeutics Among Potential Buyout Candidates: Oppenheimer
Janux Therapeutics CEO Sells $1.4M in Common Stock
LifeSci Capital Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $100
No Data
Clement Lemons : okk
章允量 :
103575541 :
RetireWise : Ho ho ho... Santa Claus is coming to town
Adrianlim90 : 1
View more comments...